01 7Venofer
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 273
2019 Revenue in Millions : 257
Growth (%) : 6
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 309
2020 Revenue in Millions : 271
Growth (%) : 23
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 359
2021 Revenue in Millions : 309
Growth (%) : 16
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 395
2022 Revenue in Millions : 358
Growth (%) : 25
Main Therapeutic Indication : Blood Disorders
Currency : USD
2017 Revenue in Millions : 263
2016 Revenue in Millions : 283
Growth (%) : -7
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 280
2017 Revenue in Millions : 246
Growth (%) : 14%
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 259
2018 Revenue in Millions : 289
Growth (%) : -11
LOOKING FOR A SUPPLIER?